MONTREAL, QUEBEC--(Marketwire - June 27, 2008) - Ambrilia Biopharma Inc. (TSX:AMB) today announced the departure of Dr. Jinzi Wu as Vice-President, Preclinical and Basic Research, effective immediately. Dr. Wu is leaving the Company to join a major pharmaceutical company in the U.S.
